DCF — LOS ANGELES GENERAL MEDICAL CENTER
Enterprise Value: $1.7B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.7B
Enterprise Value
$448.5M
PV of Cash Flows
$1.2B
PV of Terminal Value
$2.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.0B | $215.0M | 11.0% | $88.5M | $80.5M |
| Year 2 | $2.1B | $242.3M | 12.0% | $106.7M | $88.2M |
| Year 3 | $2.1B | $270.9M | 13.0% | $126.0M | $94.7M |
| Year 4 | $2.2B | $290.1M | 13.0% | $138.0M | $94.3M |
| Year 5 | $2.3B | $304.5M | 13.0% | $146.4M | $90.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.7B. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.10160939495360505
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5